Bionic clothing firm lands additional $12m for mobility enhancing tech

Cionic boosts Series A to $25m to expand adoption of its neural sleeve product.

Neurotech company Cionic has secured an additional $12 million, bringing its total Series A funding to $25 million. Founded by technology innovator Jeremiah Robison, the company aims to exceed human capability expectations and enhance mobility via a range of bionic clothing products.

Cionic is the developer of the FDA-cleared Cionic Neural Sleeve, a wearable neuromodulation platform that it claims provides more independent movement than traditional mobility aids. The sleeve is a wearable device that provides real-time assistance to support more natural and controlled body movements. The bionic garment leverages a dense array of sensors to monitor body positioning and muscle activity, predicts intended movements by analyzing brain signals and employs algorithms to optimize muscle activation patterns, providing real-time adjustment of the user’s movements.

The new funding will be used to expand the adoption of the Cionic Neural Sleeve among people affected by mobility impairments. The investment will also support the development of the company’s product pipeline to address a broader spectrum of human mobility issues.

“There is a revolution underway in healthcare and with it a growing demand for brands that provide not only high-quality care where and when it is needed, but that are also capable of measuring progress and proving outcomes,” said Robison. “Our partners recognize that we are building something truly unique, and we are proud to work with organizations who share not only our vision for the future of healthcare, but whose deep expertise in brand building, healthcare transformation, and disability advocacy will help us accelerate the timeline for making this vision a reality.”

Over the past six months, Cionic has doubled its workforce and opened a state-of-the-art manufacturing facility in Northern California. The company is now authorized to ship the Cionic Neural Sleeve to 45 states in the United States, serving over 400 prescribing institutions.

The Series A extension, led by consumer-focused investment firm L Catterton, also included new investor THVC alongside existing backers. Whitney Casey, a Venture Partner at L Catterton, joins Cionic’s Board of Directors.

“Transformative technologies are powering a new category of consumer medical devices that assist anywhere it is needed, and at any time,” said Casey. “We have seen how CIONIC’s unique bionic clothing has already transformed the lives of those living with mobility impairments, and with the growing consumer interest in wearable health technology, CIONIC’s platform has the potential to change the trajectory of personalized healthcare, and clothing, as we know it.”

Photo courtesy of Cionic